Loading…

The E2F Transcription Factor 1 Transactives Stathmin 1 in Hepatocellular Carcinoma

Background Through data mining the Stanford Microarray Database, the stathmin 1 ( STMN1 ) transcript was found to be frequently upregulated in the hepatocellular carcinoma (HCC) with low alpha-fetoprotein level. The molecular mechanism of STMN1 upregulation in HCCs remained unclear. Methods Quantita...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgical oncology 2013-11, Vol.20 (12), p.4041-4054
Main Authors: Chen, Yi-Ling, Uen, Yih-Huei, Li, Chien-Feng, Horng, Kuo-Chan, Chen, Lih-Ren, Wu, Wen-Ren, Tseng, Hong-Yu, Huang, Hsuan-Ying, Wu, Li-Ching, Shiue, Yow-Ling
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Through data mining the Stanford Microarray Database, the stathmin 1 ( STMN1 ) transcript was found to be frequently upregulated in the hepatocellular carcinoma (HCC) with low alpha-fetoprotein level. The molecular mechanism of STMN1 upregulation in HCCs remained unclear. Methods Quantitative RT-PCR, immunoblotting, immunohistochemistry, and transfection of expression or small hairpin RNA interference plasmids, chromatin immunoprecipitation (ChIP), and quantitative ChIP assays were performed in HCC specimens or 2 distinct HCC-derived cell lines. Dual luciferase assay and site-directed mutagenesis were applied to analyze the activities of STMN1 proximal promoter region. Results STMN 1 mRNA and proteins were significantly associated with several clinicopathological features. High STMN1 or E2F1 immunoexpression was predictive of poor overall survival (OS) rate ( P  
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-012-2519-8